Scholars Central

Conference abstractPublished 27 Jun 2016

Growth potential of biosimilar products in Bangladesh

Authors: Md Abu Zafor Sadek

Renata Limited, Bangladesh

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In view of the global changes in disease pattern, reduced health budget, patent expiry of some high valued products and side effects of chemical drugs, global pharmaceutical giants are concentrating on biotech products among which anticancer, cardiovascular, antidiabetic, antiasthmatic, antiarthritic products are specially important. However, developing a biotech product involved huge cost which is possible only by research based top companies. Realizing the fact, many pharmaceutical companies tried to imitate the original biotech products after patent expiry and became successful which bring a breakthrough in terms of health cost. These imitated products are termed as biosimilar products. Considering present stumpy growth in pharmaceuticals, geographical location, economic growth, drug policies, expertise etc Bangladesh may be an impressive hub for rapid growth of biosimilar products. Therefore, this study will concentrate to determine the growth potential of biosimilar products in Bangladesh.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioanalysis & Biomedicine
  • BylineArticles whose byline prints “Md Abu Zafor Sadek”